IMCD (OTCMKTS:IMDZF – Get Rating) was the recipient of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 243,900 shares, a decrease of 5.8% from the April 15th total of 258,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,439.0 days.
IMCD Stock Performance
IMDZF opened at $151.26 on Tuesday. The business’s fifty day moving average is $155.85 and its two-hundred day moving average is $149.16. IMCD has a one year low of $114.14 and a one year high of $177.44.
Wall Street Analyst Weigh In
Separately, Morgan Stanley assumed coverage on IMCD in a report on Wednesday, January 25th. They set an “equal weight” rating on the stock.
About IMCD
IMCD NV engages in the sale, marketing, and distribution of specialty chemicals and ingredients. It operates through following segments: Europe, Middle East, and Africa (EMEA); Americas; Asia-Pacific; and Holding Companies. The EMEA segment includes companies in Europe, Turkey, Israel, United Arab Emirates, and Africa.
Featured Articles
- Get a free copy of the StockNews.com research report on IMCD (IMDZF)
- FREYR Battery Is An Interesting Play On EVs: At Rock Bottom
- Analysts Upgrade GXO Logistics, Its First Quarter Says It All
- The Bottom Is In For AppLovin; Reversal Is NextÂ
- Exact Sciences Serves Investors Exactly What They Wished For
- Shockwave Medical, Fast Grower, In Boston Scientific’s Sights?
Receive News & Ratings for IMCD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMCD and related companies with MarketBeat.com's FREE daily email newsletter.
